Trademark Overview
On Thursday, June 20, 2002, a trademark application was filed for HYSINTH with the United States Patent and Trademark Office. The USPTO has given the HYSINTH trademark a serial number of 76423466. The federal status of this trademark filing is ABANDONED - EXPRESS as of Monday, July 21, 2003. This trademark is owned by Pfizer Inc.. The HYSINTH trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical preparations for the treatment of cardiovascular disease, central nervous system diseases and disorders, neurological disorders, urological, urogenital and urinary disorders, gastrointestinal disorders, musculosketetal disorders, allergies, diabetes, hypertension, erectile dysfunction, sexual dysfunction, stroke, cancer, migraines, pain, obesity, inflammation and inflammatory diseases, respiratory and infectious diseases, and immunological, bacterial, viral and fungal disorders; pharmaceutical preparations, namely, smoking cessation preparations, tissue and skin repair preparations, dermatological preparations, and gynecological preparations